• finortex-quimica-fina

Research, development and manufacture of active ingredients and advanced intermediates

Production

Production

The main work of Finortex is the manufacture of active ingredients and advanced intermediates for pharmaceutical use, both for human and veterinary purposes.

Our facilities and equipment are set up to guarantee that production can take place on various scales, adapting to our customers’ requirements.

Finortex is set apart by the close and loyal dealings that we have with our customers, and we have exclusivity contracts with the majority of them.

Quality Control

Quality Control

The quality control department carries out the physical-chemical analysis of raw materials, intermediate and finished products (API), as well as other tests, using a wide variety of analytical techniques (HPLC, GC, FT-IR, etc.)

Other operations performed in our laboratory are the development and validation of analytical methods, stability control, cleaning validation, and so on.

Research and Development (R&D)

Research and Development (R&D)

Research is a key part of Finortex. Our main projects focus on research into new synthesis methods, as well as optimizing existing processes.

Regulatory services

Regulatory services

Finortex has had DMFs authorized throughout the European Union and is experienced at obtaining CEPs. Our technical staff, together with front-line advisors, make up a team that is very competent in the field of regulations.

FINORTEX SL, uses "COOKIES" to ensure the proper functioning of our web portal, improving security, for superior efficiency and customization, to collect statistical data.
Click "ACCEPT" to authorize their use or "REFUSE" to reject them. In this case FINORTEX SL cannot guarantee the full functionality of the page. You can find more information in our COOKIES POLICY here or at the bottom of the page.
More information Accept Refuse